Joseph Albanese, PhD Janssen Pharmaceuticals R&D, LLC (Johnson and Johnson)

Joseph Albanese, Ph.D. holds a doctoral degree in Chemistry from the University of Delaware. Dr. Albanese has more than 25 years of pharmaceutical industry and managerial experience. He is currently the Director of Analytical Strategy and Compliance at Janssen Research and Development, LLC. Joe provides oversight of regulatory intelligence that impact developmental and commercial products. He is the single point of contact for China projects such as Pharmacopoeia, Product Importation, and Generic Consistency Evaluation. He is defining a strategy to ensure all projects in development comply to key emerging markets regulations for analytical development and stability. He is also responsible for the compendial vigilance process for all Janssen ensuring compliance with US, European, Japanese, British, Chinese, Indian, and Russian pharmacopoeias.

Joe is active in industry working groups; PhRMA Limited Duration Key Item Team for compendial issues with USP, the EFPIA Biotherapeutics subteam for the elaboration of biotherapeutic compendial standards, and the USP General Notices Project Team. He is active in industry trade organizations such as NJPQCA and PDA. Joe has held various analytical and quality positions throughout his career, including leading an analytical method/validation laboratory, quality control laboratories for small molecules and biotherapeutics products, and laboratories for product stability management.